Anthony Eccleston

Evaluation of Cancer-Based Criteria for Use in Mainstream<i>BRCA1</i>and<i>BRCA2</i>Genetic Testing in Patients With Breast Cancer

Zoe Kemp, Alice Turnbull, Shawn Yost et al. · JAMA Network Open · 2019 · 114 citations · Full text

A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian Cancer

Anthony Eccleston, Anthony Bentley, Matthew Dyer et al. · Value in Health · 2017 · 71 citations · Full text

Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial

Neal D. Shore, Thomas Powles, Jens Bedke et al. · Nature Medicine · 2025 · 42 citations · Full text

Canadian cost-effectiveness model of BRCA-driven surgical prevention of breast/ovarian cancers compared to treatment if cancer develops

M. Hurry, Anthony Eccleston, Matthew Dyer et al. · International Journal of Technology Assessment in Health Care · 2020 · 18 citations · Full text

Targeted surgical prevention of epithelial ovarian cancer is cost effective and saves money in BRCA mutation carrying family members of women with epithelial ovarian cancer. A Canadian model

Paul Hoskins, Anthony Eccleston, M. Hurry et al. · Gynecologic Oncology · 2019 · 14 citations

Surgical Oncology, Gynecological Surgery, Brca Mutation +10